FDA Panel Will Meet June 15 To Discuss COVID Shots For Kids Under 5

FDA’s vaccine advisers are expected to meet June 15 to discuss Pfizer’s and Moderna’s COVID-19 vaccines for kids ages 6 months to 4 years and 6 months to 5 years, respectively, the agency announced Monday (May 23). The announcement came just hours after Pfizer released data showing its three-dose vaccine showed a strong immune response in kids. The meeting date is tentative, as both companies are still completing their emergency use authorization applications. The advisers also will meet June 14...